Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Holger Rumpold

11PUBLICATIONS
30CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

Sort by Publication Date:
|Dec 30, 2025
Rapid Hematological and Molecular Response to Pegylated Interferon in WHO-Defined Pre-Fibrotic Myelofibrosis.

Sigrid Machherndl-Spandl, Marcel Kiehberger, Veronika Sygulla

|Feb 04, 2025
Baseline Liquid Biopsy in Relation to Tissue-Based Parameters in Metastatic Colorectal Cancer: Results From the Randomized FIRE-4 (AIO-KRK-0114) Study.

Sebastian Stintzing, Susanne Klein-Scory, Ludwig Fischer von Weikersthal

|Dec 17, 2024
Circulating Tumor DNA (ctDNA) Dynamics Predict Early Response to Treatment in Metastasized Gastroesophageal Cancer (mGEC) After 2 Weeks of Systemic Treatment.

Stefan Tatalovic, Bernhard Doleschal, Alexander Kupferthaler

|Oct 16, 2024
Improved Outcomes in Myelofibrosis after Allogeneic Stem-Cell Transplantation in the Era of Ruxolitinib Pretreatment and Intensified Conditioning Regimen-Single-Center Analysis.

Sigrid Machherndl-Spandl, Sarah Hannouf, Alexander Nikoloudis

|Oct 03, 2023
Response prediction by mutation- or methylation-specific detection of ctDNA dynamics in pretreated metastatic colorectal cancer.

Bernhard Doleschal, Patrick Kirchweger, Simon Schwendinger

|Jan 03, 2022
Improvement in colorectal cancer outcomes over time is limited to patients with left-sided disease.

Holger Rumpold, M Hackl, A Petzer

Pageof 2

Frequent Collaborators

3 joint publications

Gerald Webersinke

2 joint publications

Alexander Kupferthaler

2 joint publications

Otto Zach

2 joint publications

Irene Strassl

2 joint publications

Wolfgang Schimetta

2 joint publications

Johannes Clausen

2 joint publications

Veronika Buxhofer-Ausch

1 joint publications

Melanie Rammer

1 joint publications

Hubert Hackl

1 joint publications

Pornpimol Charoentong

Frequent Collaborators

3 joint publications

Gerald Webersinke

2 joint publications

Alexander Kupferthaler

2 joint publications

Otto Zach

2 joint publications

Irene Strassl

Top Related Videos

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on : Jun 17, 2025

850
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on : Mar 14, 2019

5.4K
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on : Jun 08, 2019

8.6K
See more related videos

Top Related Videos

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on : Jun 17, 2025

850
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on : Mar 14, 2019

5.4K
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on : Jun 08, 2019

8.6K
See more related videos